New marker of drug response may speed pace of lung cancer prevention trials
January 8, 2013 · Comments Off
Testing medicines to prevent lung cancer requires treating many thousands of high-risk individuals and then waiting 5, 10 or 15 years for results. A possible waypoint on the way to benefit may dramatically speed testing.
How chronic obstructive pulmonary disease increases risk of lung cancer
July 24, 2012 · Comments Off
In addition to the well-known risk factor of smoking, chronic obstructive pulmonary disease (COPD) increases lung cancer risk.
Milk thistle shows promise for prevention of colorectal cancer in new CU Cancer Center study
October 1, 2010 · Comments Off
Silibinin (a milk thistle extract active agent)decreased the growth of colon tumors in mice when...
NTRK1: a new oncogene and target in lung cancer
October 1, 2010
NEJM: Crizotinib Effective in Phase 1 Trial Against ROS1 Lung Cancer
September 30, 2014 · No comments
ALK amc cancer fund American Association for Cancer Research andrew thorburn anthony elias antonio jimeno ASCO biomarkers bladder cancer breast cancer cancer cancer grants cancer research colorado cancer stem cells Cancer Survivorship clinical trial colorado cancer benefit colorectal cancer crizotinib CU Cancer Center Dan Theodorescu fred hirsch funding opportunity grant james degregori jennifer richer leukemia lung cancer lung cancer research melanoma microRNA ovarian cancer Pancreatic cancer paul bunn prostate cancer publications rajesh agarwal ross camidge skin cancer Thomas Flaig tim byers university of colorado cancer center university of colorado hospital university of colorado school of medicine wells messersmith
Another fantastic article by our guest blogger Celia Ruiz Tomlinson. fb.me/2HHwiDGD0
CU Cancer Center researcher looks into female sexual health after cancer treatment. “This is a subject that no... fb.me/6OkYVDAdD
Race for the Cure is tomorrow! We hope to see you there! fb.me/6BZ6FkEi0